Abstract
SummaryEvidence supports a role of antibody-dependent cellular cytotoxicity (ADCC) toward transitional epitopes in the first and second constant (C1-C2) regions of gp120 (A32-like epitopes) in preventing HIV-1 infection and in vaccine-induced protection. Here, we describe the first successful attempt at isolating the inner domain (ID) of gp120 as an independent molecule that encapsulates the A32-like region within a minimal structural unit of the HIV-1 Env. Through structure-based design, we developed ID2, which consists of the ID expressed independently of the outer domain and stabilized in the CD4-bound conformation by an inter-layer disulfide bond. ID2 expresses C1-C2 epitopes in the context of CD4-triggered full-length gp120 but without any known neutralizing epitope present. Thus, ID2 represents a novel probe for the analysis and/or selective induction of antibody responses to the A32 epitope region. We also present the crystal structure of ID2 complexed with mAb A32, which defines its epitope.
Highlights
Numerous studies have indicated a relevant role for Fc receptor (FcR)-effector functions including antibody-dependent cellular cytotoxicity (ADCC) in protective immunity, as these responses have been shown to correlate with slower progression of HIV disease (Jia et al, 2013; Wren et al, 2013) or decreased virus replication
Design and Purification of an Independent Inner Domain Molecule, ID1 Our previous structural analysis of complexes formed between A32-like monoclonal Abs (mAbs) and the gp120 antigen indicated that A32-like mAbs invariantly recognize the epitope surface around the b1, b2 strands and the a0 and a1 helices of layers 1 and 2 of the inner domain (ID) of gp120 in its CD4-bound conformation (Acharya et al, 2014; Gohain et al, 2015)
We hypothesized that an independent ID molecule, with the V1V2 loop deleted and preferentially stabilized in the CD4-bound conformation, would be a suitable minimal structure for presenting A32-like epitopes with the same antigenic features as seen in gp120-CD4 complexes
Summary
Numerous studies have indicated a relevant role for Fc receptor (FcR)-effector functions including antibody-dependent cellular cytotoxicity (ADCC) in protective immunity, as these responses have been shown to correlate with slower progression of HIV disease (Jia et al, 2013; Wren et al, 2013) or decreased virus replication. The A32-like entry targets become exposed during the initial steps of viral entry after Env trimers engage the host CD4 receptor and, possibly, the co-receptor They persist on newly infected cell surfaces for extended periods of time (Finnegan et al, 2001, 2002; Mengistu et al, 2015) where they have the capacity to mediate Fc-effector functions in vitro (Guan et al, 2013; reviewed in Lewis et al, 2014; Pollara et al, 2013; Veillette et al, 2016). The picture is even stronger for vaccine-induced immunity in humans, as the A32-like
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have